Key result
Tricuspid annuloplasty during mitral surgery linked to ~6-point lower 10-year moderate or severe TR.
Why the study?
Management of functional tricuspid regurgitation consequences on outcome in degenerative mitral regurgitation remains controversial due to lack of large series with rigorous guideline application and long-term echocardiographic follow-up.
Cohort (n=441)
Yes
Answers are grounded in this paper and cite their sources.
Supports guideline-based tricuspid annuloplasty in mitral repair; leaves open randomized confirmation of clinical benefit.
Objectives Despite coherent guidelines, management of functional tricuspid regurgitation (FTR) consequences on outcome in the context of degenerative mitral regurgitation (DMR) remains controversial due to lacking series of large magnitude with rigorous application of tricuspid guidelines and strict long-term echocardiographic follow-up. Thus, we aimed at gathering such a cohort to examine outcomes of patients undergoing DMR surgery following tricuspid surgery guidelines. Methods All consecutive patients with isolated DMR 2005-2015 operated on with baseline FTR assessment and tricuspid annulus diameter measurement were identified. Operative complications, postoperative tricuspid regurgitation incidence, and survival were assessed overall and stratified by guideline-based tricuspid annuloplasty (TA) indication (severe FTR or tricuspid annulus diameter ≥40 mm). Results Among 441 patients with DMR undergoing mitral repair (66 ± 13 years, 30% female, ejection fraction 66 ± 10%, systolic pulmonary artery pressures 39 ± 12 mm Hg) followed 6 [3-9] years, patients with TA (n = 234, 53%) had generally similar presentation versus without TA (n = 207, 47%; all P ≥ .2) except for more atrial fibrillation and larger left ventricle (both P ≥ .0003). Patients with TA showed longer bypass time, more maze procedures (all P ≤ .001), but hospital stay, renal-failure, pacemaker implantation, and operative mortality (overall 0.9%) were comparable (all P ≥ .2). Postoperative incidence of moderate/severe FTR (0% at 1 year) became over time greater among patients without TA (5-year 8% [4%-13%] vs 3% [1%-11%] and 10-year 10% [6%-16%] vs 4% [1%-16%], P = .01). Survival (95% confidence interval) throughout follow-up was 85% (77%-89%) at 10 years, with hazard ratio 0.57 (0.29-1.10), P = .09. for patients with TA versus without. Conclusions In this large surgical DMR cohort, guideline-based FTR management was safe and effective. While long-term mortality did not reach significance, postoperative incidence of moderate/severe FTR, overall low, was nevertheless greater in patients who did not appear to require TA at surgery and linked to tricuspid annular dimension. Thus, future multicenter prospective cohorts with long-term follow-up are warranted to re-examine thresholds for TA performance and impact on survival.
No takes yet. Share an insight, caveat, or question.
Dreyfus et al. (2021) conducted a cohort in Degenerative mitral regurgitation (DMR) (n=441). Guideline-based tricuspid annuloplasty (TA) vs. No tricuspid annuloplasty (TAd <40 mm) was evaluated on Postoperative cumulative incidence of moderate/severe functional tricuspid regurgitation (p=0.01). Guideline-based tricuspid annuloplasty during degenerative mitral regurgitation surgery reduced the 10-year incidence of moderate or severe functional tricuspid regurgitation compared to no annuloplasty.
Synapse has enriched 10 related papers. Consider them for comparative context: